Kristen  Williams net worth and biography

Kristen Williams Biography and Net Worth

Chief Administrative Officer & Secretary of Pacira BioSciences

Kristen Williams worked with the company as a legal consultant before joining as Corporate Counsel in December 2011. Since then, she has been promoted to Vice President, General Counsel in 2013 and to Chief Administrative Officer, General Counsel and Secretary in 2014. Prior to joining Pacira, she was Vice President, Corporate Compliance and Assistant General Counsel for Bioenvision, Inc from June 2004 until its merger with Genzyme Corporation in 2007. From September 1999 to June 2004, she practiced corporate law at Paul Hastings LLP in New York, where her practice encompassed all aspects of public and private mergers and acquisitions, corporate finance, and securities law and compliance, with a core focus in the healthcare industry.

Ms. Williams earned a Bachelor of Science Degree in Business Administration from Bucknell University and a J.D. Degree from the University of Denver, College of Law in Denver, CO.

What is Kristen Williams' net worth?

The estimated net worth of Kristen Williams is at least $2.38 million as of June 13th, 2024. Ms. Williams owns 102,912 shares of Pacira BioSciences stock worth more than $2,377,267 as of April 7th. This net worth evaluation does not reflect any other investments that Ms. Williams may own. Additionally, Ms. Williams receives a salary of $799,630.00 as Chief Administrative Officer & Secretary at Pacira BioSciences. Learn More about Kristen Williams' net worth.

How old is Kristen Williams?

Ms. Williams is currently 50 years old. There are 6 older executives and no younger executives at Pacira BioSciences. The oldest executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who is 74 years old. Learn More on Kristen Williams' age.

What is Kristen Williams' salary?

As the Chief Administrative Officer & Secretary of Pacira BioSciences, Inc., Ms. Williams earns $799,630.00 per year. There are 2 executives that earn more than Ms. Williams. The highest earning executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who commands a salary of $1,540,000.00 per year. Learn More on Kristen Williams' salary.

How do I contact Kristen Williams?

The corporate mailing address for Ms. Williams and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at susan.mesco@pacira.com. Learn More on Kristen Williams' contact information.

Has Kristen Williams been buying or selling shares of Pacira BioSciences?

Kristen Williams has not been actively trading shares of Pacira BioSciences over the course of the past ninety days. Most recently, Kristen Williams sold 7,452 shares of the business's stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $28.38, for a transaction totalling $211,487.76. Following the completion of the sale, the insider now directly owns 102,912 shares of the company's stock, valued at $2,920,642.56. Learn More on Kristen Williams' trading history.

Who are Pacira BioSciences' active insiders?

Pacira BioSciences' insider roster includes Marcelo Bigal (Director), Mark Froimson (Director), Mark Kronenfeld (Director), Frank Lee (Chief Executive Officer & Director), Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), Jonathan Slonin (Chief Medical Officer), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), Kristen Williams (Chief Administrative Officer & Secretary), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.

Are insiders buying or selling shares of Pacira BioSciences?

In the last twelve months, Pacira BioSciences insiders bought shares 3 times. They purchased a total of 11,176 shares worth more than $136,240.40. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 23,974 shares worth more than $653,601.25. The most recent insider tranaction occured on January, 6th when insider Jonathan Slonin sold 879 shares worth more than $16,173.60. Insiders at Pacira BioSciences own 6.4% of the company. Learn More about insider trades at Pacira BioSciences.

Information on this page was last updated on 1/6/2025.

Kristen Williams Insider Trading History at Pacira BioSciences

See Full Table

Kristen Williams Buying and Selling Activity at Pacira BioSciences

This chart shows Kristen Williams's buying and selling at Pacira BioSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200k-$100k$0$100k$200kTotal Insider BuyingTotal Insider Selling

Pacira BioSciences Company Overview

Pacira BioSciences logo
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Read More

Today's Range

Now: $23.10
Low: $22.63
High: $24.03

50 Day Range

MA: $24.88
Low: $22.04
High: $27.25

2 Week Range

Now: $23.10
Low: $11.16
High: $31.67

Volume

692,277 shs

Average Volume

937,919 shs

Market Capitalization

$1.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.7